Metavante adds CapMed to healthcare information business
This article was originally published in Clinica
Metavante Technologies has bolstered its medical information and payment processing operations with the acquisition of CapMed, a division of healthcare contract service firm Bio-Imaging Technologies. The sale of CapMed, which specialises in interactive personal health management solutions for the healthcare and pharma sectors, will allow Bio-Imaging to focus on its core business of providing clinical trial services, said the firm’s president and CEO Mark Weinstein. The transaction will see Metavante pay Bio-Imaging $500,000 in cash, with an undisclosed earn-out over a two-year period. Bio-Imaging (Milwaukee, Wisconsin) said that it expects the deal to result in a one-time charge of $2.5-2.7m. The Newtown, Pennsylvania-based company lowered its full-year 2008 earnings guidance from $0.23-0.25 per share to $0.11-0.15 as a result of this one-off charge.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals